Kathy has specialized training in EMDR (a specialized treatment to aid in trauma recovery), Sand Tray Therapy (an experiential alternative to talk therapy), and Emotion Focused Couples Therapy (a couples
therapy model based on discovering and meeting attachment needs).
Not exact matches
Working at Heartland Alliance in Chicago allowed me to provide case management and individual
therapy to adults drawing from the following evidence - based models I am trained in and find to be effective: Family Centered Treatment (FCT), Cognitive - Behavioral Therapy (CBT), Dialectical - Behavioral Therapy (DBT) and Mindfulness Based Stress Reduction
therapy to adults drawing from the following evidence -
based models I am trained in and find to be effective: Family Centered Treatment (FCT), Cognitive - Behavioral Therapy (CBT), Dialectical - Behavioral Therapy (DBT) and Mindfulness Based Stress Reduction (M
based models I am trained in and find to be effective: Family Centered Treatment (FCT), Cognitive - Behavioral
Therapy (CBT), Dialectical - Behavioral Therapy (DBT) and Mindfulness Based Stress Reduction
Therapy (CBT), Dialectical - Behavioral
Therapy (DBT) and Mindfulness Based Stress Reduction
Therapy (DBT) and Mindfulness
Based Stress Reduction (M
Based Stress Reduction (MBSR).
That's why the CFC's connection -
based model is
based on providing more comprehensive services for families, with independent professionals ranging from psychotherapy to parent education to neuropsychological assessments, from physical health and educational
therapy to occupational
therapy, and more.
Based on this research and clinical testing of the theory, he and his wife Julie Schwartz - Gottman have developed a solid understanding of why some relationships last and why some do not, as well as an effective
model for relationship
therapy.
We specialize in treating troubled teens with behavioral issues through a unique relationship
based therapy model.
Meredith is a Level 3 Trained Gottman Method Couples Therapist and is currently pursuing certification in this research -
based couples
therapy model.
Chantelle utilizes a strengths
based, solution - focused, brief
therapy model to help clients to courageously achieve wellness.
We specialize in helping troubled teen boys turn their lives around through a unique relationship
based therapy model.
We are dedicated to helping troubled teen boys overcome their behavioral issues through a unique relationship
based therapy model that helps them take care of the root of the problem rather than just the symptoms, as so many behavior modification programs do.
Play
therapy is a form of counseling or psychotherapy by which licensed mental health professionals use play -
based models and techniques to better communicate with and help clients, especially children, achieve optimal mental health.
Develop a play
therapy treatment plan
based on one of the above
models of trauma / grief treatment.
We offer a successful relationship
based therapy model, rather than the traditional behavior modification techniques.
This new technology offers two main advantages
based on the use of molecular tools to manipulate the genome: firstly, working
models that had not existed up until now for the study of tumour biology and, secondly, their application will eventually allow for the study of new therapeutic targets and
therapies.
Indeed, exposure of the protein produced by the nanoparticle -
based gene
therapy to the gut mucosa prevents inhibitor development and restores clotting - factor activity in mouse
models of both haemophilia A and B. «This approach really could hold big benefit for patients,» says Jörg Schüttrumpf, a transfusion - medicine specialist who led one of the studies performed at the German Red Cross Blood Donor Service in Frankfurt.
In their report that has received advance online publication in Nature Nanotechnology, a research team
based at the Wellman Center for Photomedicine at Massachusetts General Hospital (MGH) describes how a nanomedicine that combines photodynamic
therapy — the use of light to trigger a chemical reaction — with a molecular
therapy drug targeted against common treatment resistance pathways reduced a thousand-fold the dosage of the molecular
therapy drug required to suppress tumor progression and metastatic outgrowth in an animal
model.
«This camera has the potential to greatly enhance our understanding of very fast biological interactions and chemical processes that will allow us to build better
models of complex, dynamical systems such as cellular respiration, or to help doctors better deliver and monitor light -
based therapies,» says Richard Conroy, Ph.D., program director for Optical Imaging at NIBIB.
The technique «potentially provides ways to create
model systems for studying the genetic
basis of diabetes, or to discover novel
therapies to enhance existing β cells,» Ferrer says.
It appears that FL118 will be an outstanding
model on which to
base new analogs that will represent even more promising investigational
therapies for personalized cancer treatment.»
The results, published in the current issue of Human Molecular Genetics, open the door for pursuing gene editing in nonhuman primates as
models for new
therapies, including pharmacological, gene - and stem cell -
based therapies, said Keith Latham, MSU animal science professor and lead author of the study.
Investigators from Massachusetts General Hospital (MGH) and the Harvard Stem Cell Institute have developed an imageable mouse
model of brain - metastatic breast cancer and shown the potential of a stem - cell -
based therapy to eliminate metastatic cells from the brain and prolong survival.
However, clinical trials
based on promising results from these
models have not identified disease - modifying
therapies (2, 3).
The scientists said that while most
therapies are
based on the on - size - fits - all
model of medicine, «we've long recognized in cancer that every patient's tumor is different.
Developing new genetic -
based models will help overcome these challenges and lead to more effective
therapies.
«Stem cell -
based therapy for targeting skin - to - brain cancer: Stem cells loaded with oncolytic viruses show promising results in preclinical
models for targeting skin cancer metastases in the brain.»
These in turn can be used for disease
modeling and drug discovery, but hopefully one day also for cell -
based therapy of the many devastating diseases such as Alzheimer and Parkinson's Disease.
Thus, MGE, or MGE - like, precursors provide a great opportunity for cell -
based therapy in animal
models of neurological disorders linked to impaired inhibitory function.
A full realisation of the medical potential of stem cells for human health will likely depend on a reinforcement of, and development of a whole continuum of studies ranging from those in vivo using
model organisms, to cell -
based therapies in the clinic.
Using agent -
based modelling and simulation approaches, we contribute to a better understanding of disease development and / or treatment effects (e.g. the context of leukaemia treatment or gene
therapy approaches).
This, the group posits, could be a
model for stem cell -
based therapies.
Interneuron cell -
based therapy in AD and related
models: During brain development, embryonic interneuron precursors are generated in the medial ganglionic eminence (MGE) and retain a remarkable capacity for migration and integration in adult host brains, where they fully mature into functional inhibitory interneurons.
Due to the high efficiency of establishing organoid
models from different tissues and diseases, such as cancer, organoid technology allows the generation of large living biobanks of tumor organoids that are amenable for middle - throughput drug screens and may allow personalized
therapy design, as a complement to cell line and xenograft -
based drug studies (7,19).
The potential for cell
therapy to play a role in the
therapy of myelin disorders is under serious consideration,
based on years of experimentation of glial cell transplants in experimental
models.
The research team now concentrates on using CBS -
based therapy in other animal infection
models, e.g. urinary tract infection (UTI), hoping to offer a more extensive approach to combat with antibiotic resistant superbugs.
Such manufacturing
models currently exist for some biopharmaceuticals like antibody -
based therapies.
Each cell -
based treatment approach is presented as a potential
therapy for a specific disease or a disease category (e.g.: cardiovascular diseases, metabolic diseases, etc.), studied in animal
models or in humans.
Clinical Trials Research and Billing First in Human / Early Phase PET in Oncology Case -
Based Dose Reduction in Pediatric Nuclear Medicine: Practical and Necessary Radioiodine
Therapy for Hyperthyroidism: The State of the Art Spondylodiscitis: Role of Imaging for Diagnosis and Monitoring Treatment Response Current Status and Future Prospects: PET and SPECT Instrumentation Alternative Payment
Models and Value -
Based Health Care: Nuts and Bolts Maximal Tolerated Activity of Radioactive Iodine for Metastatic Thyroid Cancer Teaching Old Radiopharmaceuticals New Tricks Intraoperative Detection Devices and Probes Molecular Imaging of Lung Inflammation Standardization of Advanced PET / SPECT Data Acquisition and Analysis Thyroid Cancer Management: Novel Therapeutics and Management Options Targeting Radionuclide
Therapy in Various Non-Malignant Arthritic Conditions Using Radiosynoviorthesis (RSO) Are You Prepared for a Radiation Accident?
Ultimately, we use all this information to establish innovative culture techniques for generating unlimited neural stem cell sources for the derivation of specific types of clinically relevant neuronal or glial cells, for their use in disease
modelling and drug discovery platforms, and towards refining their efficacy for future cell replacement -
based therapy.
«Completing the Human Cell Atlas is a mammoth task that needs the participation of many international collaborations and the combined knowledge -
base will be an immeasurably valuable tool to
model the plethora of dynamic components that enable life and to create a resource that can be used to explore new ideas for
therapies and diagnostics in the near future».
These experiments are innovative because they seek to improve a mouse
model based on current knowledge from human disease, while also testing novel
therapies that could be of benefit for affected individuals.
Dr. Falk is also PI of an NIH, pharma, and philanthropic funded translational research laboratory group at CHOP that investigates the causes and global metabolic consequences of mitochondrial disease, as well as targeted
therapies, in C. elegans, zebrafish, mouse, and human tissue
models of genetic -
based respiratory chain dysfunction, and directs multiple clinical treatment trials in mitochondrial disease patients.
In contrast to the current drugs that target one protein or one mechanism, microRNA -
based AMD
therapy provides a unique «one - molecule, multiple - targets»
model for disease treatment, which fits particularly well with the complex nature of AMD.
Robert D. Schreiber, Ph.D., an associate director of CRI's Scientific Advisory Council
based at Washington University School of Medicine in Saint Louis, Missouri, developed a new
model of breast cancer that more closely resembles the progression of hormone receptor - positive disease in humans, overcoming a major obstacle in the study of breast cancer and the development of new immune -
based therapies for the disease.
Lysogene collaborates with University of Massachusetts Medical School (UMMS) for pre-clinical efficacy studies of innovative AAV -
based gene
therapy approaches in the GM1 gangliosidosis mouse
model.
These two properties (self - renewal and pluripotency) confers human pluripotent stem cells a unique interest for clinical applications since they could allow the production of infinite quantities of cells for disease
modelling, drug screening and cell
based therapy.
The Integrative and Functional Nutrition Academy ™ (IFNA ™) training program is
based on a medical nutrition
model that combines the very best of modern science, clinical wisdom and integrative
therapies.
As such, a second method 200 derived from at least one output of the first method 100 can include: receiving a biological sample from a subject S210; characterizing the subject with a form of an autoimmune condition
based upon processing a microbiome dataset derived from the biological sample S220; and promoting a
therapy to the subject with the autoimmune condition
based upon the characterization and the
therapy model S230.
I got myself into a state - funded rehab (this time
based on the cognitive behavioral
therapy model of recovery), moved into clean and sober housing, and found work as a housekeeper at a Victorian bed and breakfast on Seattle's Capitol Hill.
SUMMARY - the Registered Nurse Clinician position is responsible for the provision of direct and indirect nursing care to patients / clients receiving home infusion
therapy based on a modified primary nursing
model and for the Initiation, implementation and
Integrated Developmental, Individual Differences, and Relationship (DIR)
Based Model into all aspects of teaching by using Floortime
Therapy
Provided one - on - one support to a large client
base, nationally and internationally, regarding linear accelerator
modeling, proton
therapy treatment planning systems, and common clinical medical physics tasks.